Netherlands· NL-f68b4aed6e40
Prolastin 1000 mg, poeder en oplosmiddel voor oplossing voor infusie
A alfa1 antitrypsin product containing alfa-1-proteinase inhibitor, humaan, registered in Netherlands by Grifols Deutschland GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Alfa1 antitrypsin is registered in 11 of 19 countries.
Countries holding a registration under ATC B02AB02 (alfa1 antitrypsin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Alfa1 antitrypsin · ATC B02AB02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of alfa1 antitrypsin costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Alfa1 antitrypsin · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$261.83
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ALFA-1-PROTEINASE INHIBITOR, HUMAAN
- Manufacturer
- Grifols Deutschland GmbH
- Country
- Netherlands (NL)
- ATC code
- B02AB02
- ATC class
- Alfa1 antitrypsin
- Defined daily dose
- 0.6 g, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id33396
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02AB02
Alfa1 antitrypsin, as other registers publish it.
- SwitzerlandGlassia
- CanadaGLASSIATAKEDA CANADA INC
- SwitzerlandGlassia 20 mg/ml, InfusionslösungIDEOGEN AG
- PolandProlastinGrifols Deutschland GmbH
- PolandProlastinGrifols Deutschland GmbH
- SwitzerlandProlastin
- NetherlandsProlastin 4000 mg, poeder en oplosmiddel voor oplossing voor infusieGrifols Deutschland GmbH
- IrelandProlastin 4000 mg, powder and solvent for solution for infusionGrifols Deutschland GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/99d18df0-754c-4365-9d76-01abd8b4ca3e GET /v1/drugs/99d18df0-754c-4365-9d76-01abd8b4ca3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder en oplosmiddel voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h33396_smpc.pdf",
"strength": null,
"atc_label": "Alfa1 Antitrypsin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg33396",
"excipients": [
"NATRIUMCHLORIDE",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"WATER, GEZUIVERD"
],
"substances": [
"ALFA-1-PROTEINASE INHIBITOR, HUMAAN"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h33396.pdf",
"authorised_at": "2006/11/28",
"procedure_number": "DE/H/0472/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "33396",
"additional_monitoring": "N"
}See everything about alfa1 antitrypsin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.